Actively Recruiting
Predictive Factors for Survival in Aggressive Meningiomas
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-03-13
250
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.
CONDITIONS
Official Title
Predictive Factors for Survival in Aggressive Meningiomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient operated for atypical (grade 2) meningioma
- Patient operated for anaplastic (grade 3) meningioma
- Surgery performed between 1999 and 2019
You will not qualify if you...
- Patient lost at follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy, 00168
Actively Recruiting
Research Team
A
Alessandro Olivi, MD
CONTACT
R
Rina Di Bonaventura, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here